Shragai, T., Lavi, N., Vaxman, I., Gatt, M. E., Chubar, E., Ganzel, C., Magen, H., Luttwak, E., Mittelman, M., Trestman, S., Lebel, E., Saban, R., Vainstein, V., Zuckerman, T., Horowitz, N., Tzoran, I., Horesh, N., Lowenton-Spier, N., Melamed, N., Pereg, I., Avivi, I. and Cohen, Y. C. (2020) “Ixazomib, pomalidomide and dexamethasone in triple-class exposed multiple myeloma patients - a phase II study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301067.